Patents by Inventor Donald L. Court

Donald L. Court has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9371532
    Abstract: Lambda phages that can be used to introduce recombineering functions into host cells are disclosed. Also disclosed are plasmids that can be used to confer recombineering functions to a variety of strains of E. coli and to other bacteria, including Salmonella, Pseudomonas, Cyanobacteria, Spirochaetes. These plasmids and phages can be isolated in vitro and can be used to transform bacterial cells, such as gram negative bacteria.
    Type: Grant
    Filed: September 9, 2014
    Date of Patent: June 21, 2016
    Assignee: The United States of America as represented by the Secretary, Department of Health and Human Services
    Inventors: Donald L. Court, Simanti Datta, Nina Costantino
  • Publication number: 20140377809
    Abstract: Lambda phages that can be used to introduce recombineering functions into host cells are disclosed. Also disclosed are plasmids that can be used to confer recombineering functions to a variety of strains of E. coli and to other bacteria, including Salmonella, Pseudomonas, Cyanobacteria, Spirochaetes. These plasmids and phages can be isolated in vitro and can be used to transform bacterial cells, such as gram negative bacteria.
    Type: Application
    Filed: September 9, 2014
    Publication date: December 25, 2014
    Inventors: Donald L. Court, Simanti Datta, Nina Costantino
  • Patent number: 8859277
    Abstract: Lambda phages that can be used to introduce recombineering functions into host cells are disclosed. Also disclosed are plasmids that can be used to confer recombineering functions to a variety of strains of E. coli and to other bacteria, including Salmonella, Pseudomonas, Cyanobacteria, Spirochaetes. These plasmids and phages can be isolated in vitro and can be used to transform bacterial cells, such as gram negative bacteria.
    Type: Grant
    Filed: June 26, 2013
    Date of Patent: October 14, 2014
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Donald L. Court, Simanti Datta, Nina Costantino
  • Publication number: 20130280811
    Abstract: Lambda phages that can be used to introduce recombineering functions into host cells are disclosed. Also disclosed are plasmids that can be used to confer recombineering functions to a variety of strains of E. coli and to other bacteria, including Salmonella, Pseudomonas, Cyanobacteria, Spirochaetes. These plasmids and phages can be isolated in vitro and can be used to transform bacterial cells, such as gram negative bacteria.
    Type: Application
    Filed: June 26, 2013
    Publication date: October 24, 2013
    Inventors: Donald L. Court, Simanti Datta, Nina Costantino
  • Patent number: 8541229
    Abstract: Lambda phages that can be used to introduce recombineering functions into host cells are disclosed. Also disclosed are plasmids that can be used to confer recombineering functions to a variety of strains of E. coli and to other bacteria, including Salmonella, Pseudomonas, Cyanobacteria, Spirochaetes. These plasmids and phages can be isolated in vitro and can be used to transform bacterial cells, such as gram negative bacteria.
    Type: Grant
    Filed: January 15, 2010
    Date of Patent: September 24, 2013
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Donald L. Court, Costantino Nina
  • Publication number: 20100267093
    Abstract: Disclosed herein are methods for generating recombinant DNA molecules in cells using homologous recombination mediated by recombinases and similar proteins. The methods promote high efficiency homologous recombination in bacterial cells, and in eukaryotic cells such as mammalian cells. The methods are useful for cloning, the generation of transgenic and knockout animals, and gene replacement. The methods are also useful for subcloning large DNA fragments without the need for restriction enzymes. The methods are also useful for repairing single or multiple base mutations to wild type or creating specific mutations in the genome. Also disclosed are bacterial strains and vectors which are useful for high-efficiency homologous recombination.
    Type: Application
    Filed: April 14, 2010
    Publication date: October 21, 2010
    Inventors: Donald L. Court, Daiguan Yu, E-Chiang Lee, Hilary M. Ellis, Nancy A. Jenkins, Pentao Liu, Neal G. Copeland
  • Publication number: 20100136692
    Abstract: Lambda phages that can be used to introduce recombineering functions into host cells are disclosed. Also disclosed are plasmids that can be used to confer recombineering functions to a variety of strains of E. coli and to other bacteria, including Salmonella, Pseudomonas, Cyanobacteria, Spirochaetes. These plasmids and phages can be isolated in vitro and can be used to transform bacterial cells, such as gram negative bacteria.
    Type: Application
    Filed: January 15, 2010
    Publication date: June 3, 2010
    Inventors: Donald L. Court, Simanti Datta, Nina Costantino
  • Patent number: 7674621
    Abstract: Lambda phages that can be used to introduce recombineering functions into host cells are disclosed. Also disclosed are plasmids that can be used to confer recombineering functions to a variety of strains of E. coli and to other bacteria, including Salmonella, Pseudomonas, Cyanobacteria, Spirochaetes. These plasmids and phages can be isolated in vitro and can be used to transform bacterial cells, such as gram negative bacteria.
    Type: Grant
    Filed: May 20, 2005
    Date of Patent: March 9, 2010
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Donald L. Court, Simanti Datta, Nina Costantino
  • Patent number: 7521242
    Abstract: Methods are disclosed herein for inducing homologous recombination in a host cell comprising a target nucleic acid, using a single-stranded nucleic acid molecule. The single-stranded nucleic acid molecule has a sufficient number of nucleotides homologous to the target nucleic acid to enable homologous recombination with the target nucleic acid. The host cell includes a de-repressible promoter operably linked to a nucleic acid encoding a single-stranded binding protein and is deficient for mismatch repair. Isolated host cells of use in this method are also disclosed.
    Type: Grant
    Filed: May 7, 2004
    Date of Patent: April 21, 2009
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Donald L. Court, Xin-tian Li, Jian-Dong Huang, Nina Costantino, Depei Liu
  • Patent number: 7144734
    Abstract: Disclosed herein are methods for generating recombinant DNA molecules in cells using homologous recombination mediated by recombinases and similar proteins. The methods promote high efficiency homologous recombination in bacterial cells, and in eukaryotic cells such as mammalian cells. The methods are useful for cloning, the generation of transgenic and knockout animals, and gene replacement. The methods are also useful for subcloning large DNA fragments without the need for restriction enzymes. The methods are also useful for repairing single or multiple base mutations to wild type or creating specific mutations in the genome. Also disclosed are bacterial strains and vectors which are useful for high-efficiency homologous recombination.
    Type: Grant
    Filed: February 12, 2003
    Date of Patent: December 5, 2006
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Donald L. Court, Daiguan Yu, E-Chiang Lee, Hilary M. Ellis, Nancy A. Jenkins, Neal G. Copeland
  • Publication number: 20040092016
    Abstract: Disclosed herein are methods for generating recombinant DNA molecules in cells using homologous recombination mediated by recombinases and similar proteins. The methods promote high efficiency homologous recombination in bacterial cells, and in eukaryotic cells such as mammalian cells. The methods are useful for cloning, the generation of transgenic and knockout animals, and gene replacement. The methods are also useful for subcloning large DNA fragments without the need for restriction enzymes. The methods are also useful for repairing single or multiple base mutations to wild type or creating specific mutations in the genome. Also disclosed are bacterial strains and vectors which are useful for high-efficiency homologous recombination.
    Type: Application
    Filed: October 23, 2003
    Publication date: May 13, 2004
    Applicant: The Govt. of the USA as the Secretary of the Dept. of Health and Human Services
    Inventors: Donald L. Court, Daiguan Yu, E-Chiang Lee, Hilary M. Ellis, Nancy A. Jenkins, Pentao Liu, Neal G. Copeland
  • Publication number: 20030224521
    Abstract: Disclosed herein are methods for generating recombinant DNA molecules in cells using homologous recombination mediated by recombinases and similar proteins. The methods promote high efficiency homologous recombination in bacterial cells, and in eukaryotic cells such as mammalian cells. The methods are useful for cloning, the generation of transgenic and knockout animals, and gene replacement. The methods are also useful for subcloning large DNA fragments without the need for restriction enzymes. The methods are also useful for repairing single or multiple base mutations to wild type or creating specific mutations in the genome. Also disclosed are bacterial strains and vectors which are useful for high-efficiency homologous recombination.
    Type: Application
    Filed: February 12, 2003
    Publication date: December 4, 2003
    Applicant: The Gov. of the USA Secretary of the Department of Health and Human Services
    Inventors: Donald L. Court, Daiguan Yu, E-Chiang Lee, Hilary M. Ellis, Nancy A. Jenkins, Pentao Liu, Neal G. Copeland
  • Patent number: 6132954
    Abstract: The present invention provides for methods of screening for agents which delay the cell cycle and methods of delaying the cell cycle. Analogues of Era having arginine, histidine, or lysine at amino acid codon 17 are embodied by the present invention. Human and other homologs of bacterial Era amino acid and nucleic acid sequences are provided in the present invention. Vectors, host cells, protein preparations, cell cultures, and compositions comprising said analogue are also set forth in the present invention.
    Type: Grant
    Filed: August 20, 1997
    Date of Patent: October 17, 2000
    Assignees: Baylor College of Medicine, The United States of America as represented by the Department of Health and Human Services
    Inventors: James R. Lupski, Robert A. Britton, Donald L. Court, Bradford S. Powell